What is Bruce C. Cozadd’s share ownership in JAZZ after this grant?

After this award, Bruce C. Cozadd directly owns 362,287 ordinary shares of Jazz Pharmaceuticals. This total includes the newly granted restricted stock units, which represent a right to receive ordinary shares once vesting conditions are satisfied under the company’s director equity plan.

Jazz Pharmaceuticals (JAZZ) awards director 1,605 restricted stock units

Q: What insider transaction did Bruce C. Cozadd report for JAZZ?

Bruce C. Cozadd reported receiving 1,605 restricted stock units in Jazz Pharmaceuticals, each representing one ordinary share. This equity award was recorded with a reported price of $0.00 per share and increased his direct ownership to 362,287 ordinary shares in the company.

Q: How many JAZZ shares were covered by the restricted stock unit grant and at what price?

The grant covered 1,605 restricted stock units , each tied to one ordinary share of Jazz Pharmaceuticals. The reported transaction price per share was $0.00 , reflecting that this was an equity compensation award rather than an open-market purchase for the director.

Q: When do Bruce C. Cozadd’s JAZZ restricted stock units vest?

The 1,605 restricted stock units will vest in full on July 23, 2027 , assuming the director continues in service. Vesting is also subject to certain additional conditions specified in Jazz Pharmaceuticals’ 2007 Amended and Restated Non-Employee Directors Stock Award Plan.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

COZADD BRUCE C reported acquisition or exercise transactions in this Form 4 filing.

Bruce C. Cozadd, a director of Jazz Pharmaceuticals plc, reported an equity compensation grant of 1,605 restricted stock units, each representing one ordinary share. The award carries a reported price per share of $0.00 and will vest in full on July 23, 2027, subject to continuous service and other conditions. Following this grant, Cozadd directly holds 362,287 ordinary shares of Jazz Pharmaceuticals.

Insider Trade Summary

Net Buyer: 1,605 shares

Net Buy 1 txn

Insider COZADD BRUCE C

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares ^F1	1,605	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 362,287 shares (Direct)

Footnotes (1)

F1. These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027.

Key Figures

Restricted stock units granted: 1,605 shares Grant price per share: $0.00 Shares held after grant: 362,287 shares +2 more

5 metrics

Restricted stock units granted 1,605 shares Grant of restricted stock units to director Bruce C. Cozadd on August 5, 2026

Grant price per share $0.00 Reported transaction price per ordinary share for the restricted stock unit grant

Shares held after grant 362,287 shares Total ordinary shares directly owned by Bruce C. Cozadd following the grant

Vesting date July 23, 2027 Restricted stock units vest in full on this date, subject to conditions

Transaction date August 5, 2026 Date of reported acquisition of restricted stock units

Key Terms

restricted stock units, contingent right, continuous service, Non-Employee Directors Stock Award Plan

4 terms

restricted stock units financial

"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one ordinary share"

continuous service financial

"Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest"

Non-Employee Directors Stock Award Plan financial

"pursuant to the 2007 Amended and Restated Non-Employee Directors Stock Award Plan"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/07/2026 - 05:32 PM Accepted by SEC EDGAR 08/07/2026 - 05:31 PM

FAQ

What insider transaction did Bruce C. Cozadd report for JAZZ?

Bruce C. Cozadd reported receiving 1,605 restricted stock units in Jazz Pharmaceuticals, each representing one ordinary share. This equity award was recorded with a reported price of $0.00 per share and increased his direct ownership to 362,287 ordinary shares in the company.

How many JAZZ shares were covered by the restricted stock unit grant and at what price?

The grant covered 1,605 restricted stock units, each tied to one ordinary share of Jazz Pharmaceuticals. The reported transaction price per share was $0.00, reflecting that this was an equity compensation award rather than an open-market purchase for the director.

When do Bruce C. Cozadd’s JAZZ restricted stock units vest?

The 1,605 restricted stock units will vest in full on July 23, 2027, assuming the director continues in service. Vesting is also subject to certain additional conditions specified in Jazz Pharmaceuticals’ 2007 Amended and Restated Non-Employee Directors Stock Award Plan.

Was the JAZZ insider grant reported as made under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not marked, indicating this 1,605-unit equity grant was not reported as occurring under a Rule 10b5-1 trading arrangement. It appears as a standard director stock award, rather than part of a pre-set trading plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

COZADD BRUCE C

(Last)

(First)

(Middle)

5TH FL, WATERLOO EXCHANGE

WATERLOO RD

(Street)

DUBLIN 4

(City)

(State)

(Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Jazz Pharmaceuticals plc [ JAZZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	08/05/2026		A⁽¹⁾		1,605	A	$0.0	362,287	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027.

	By: /s/Paz Dizon, as attorney in fact For: Bruce C. Cozadd	08/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR